Background Identifying reliable prognostic markers is crucial for the effective management of
hypertension. The neutrophil-to-lymphocyte ratio (NLR) has emerged as a potential …

Background Evidence regarding the neutrophil–lymphocyte ratio (NLR) and mortality risk in
diabetes patients is scarce. This study investigated the relationship of the NLR with all-cause …

Based on a cohort in Tianjin, China, we explore the relationship between neutrophils-to-
lymphocyte ratio (NLR) and the risk of cardiovascular diseases (CVDs). From January 2010 …

The neutrophil-to-lymphocyte ratio (NLR) has received much attention in recent decades
and has been a novel inflammatory marker. NLR has been applied in predicting the …

Background Inflammation plays an important role in atherosclerosis. The neutrophil-to-
lymphocyte ratio (NLR) may serve as a clinically useful biomarker of inflammation and …

This study systematically reviewed the evidence regarding differences in the neutrophil to
lymphocyte ratio (NLR) level between hypertensive and normotensive individuals as well as …

Objective To further supplement the previous research on the relationship between
neutrophil–lymphocyte ratio (NLR) and all-cause and cardiovascular mortality, and construct …

BACKGROUND Hypertension is a significant global public health challenge. Low-grade
inflammation is known to facilitate the development of essential hypertension and target …

Background Neutrophil-lymphocyte ratio (NLR) is a novel marker of inflammation. Emerging
studies have evaluated the relationship of NLR with cardiovascular diseases and malignant …

Background Increasing insights have supported the role of inflammation in progression of
atherosclerotic cardiovascular disease. Numerous reports have suggested that levels of the …